Literature DB >> 1898369

The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs.

L J Askonas1, J W Ricigliano, T M Penning.   

Abstract

Rat liver 3 alpha-hydroxysteroid dehydrogenase (3 alpha-HSD) (EC 1.1.1.50) is an NAD(P)(+)-dependent oxidoreductase that is potently inhibited at its active site by non-steroidal anti-inflammatory drugs (NSAIDs). Initial-velocity and product-inhibition studies performed in either direction at pH 7.0 are consistent with a sequential ordered Bi Bi mechanism in which pyridine nucleotide binds first and leaves last. This mechanism is supported by fluorescence titrations of the E-NADH complex, and by the failure to detect the binding of either [3H]androsterone or [3H]androstanedione to free enzyme by equilibrium dialysis. Dead-end inhibition studies with NSAIDs also support this mechanism. Initial-velocity studies with indomethacin show that this drug is an uncompetitive inhibitor against NAD+, but a potent competitive inhibitor against androsterone, indicating the ordered formation of an E.NAD+.indomethacin complex. Calculation of the individual rate constants reveals that the binding and release of pyridine nucleotide is rate-limiting and that isomerization of the central complex is favoured in the forward direction. Equilibrium dialysis experiments with [14C]indomethacin reveal the presence of two abortive NSAID complexes, a high-affinity ternary complex corresponding to E.NAD+.indomethacin (Kd = 1-2 microM for indomethacin) and a low-affinity binary complex corresponding to E.indomethacin (Kd = 22 microM for indomethacin). Since indomethacin has a low affinity for free enzyme, the formation of this abortive binary complex does not complicate kinetic measurements which are made in the presence of NAD+, but may contribute to the inhibition of the enzyme by NSAIDs. Using either pro-R-[4-3H]NADH or pro-S-[4-3H]NADH as cofactor, radiolabelled androsterone was formed only when the pro-R-[4-3H]NADH was used, confirming that purified 3 alpha-HSD is a Class A dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898369      PMCID: PMC1151422          DOI: 10.1042/bj2780835

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  The enzymatic transfer of hydrogen. VI. The reaction catalyzed by D-glyceraldehyde-3-phosphate dehydrogenase.

Authors:  H R LEVY; F A LOEWUS; B VENNESLAND
Journal:  J Biol Chem       Date:  1956-12       Impact factor: 5.157

2.  Structural similarity of bovine lung prostaglandin F synthase to lens epsilon-crystallin of the European common frog.

Authors:  K Watanabe; Y Fujii; K Nakayama; H Ohkubo; S Kuramitsu; H Kagamiyama; S Nakanishi; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Inhibition of 3(17)beta-hydroxysteroid dehydrogenase from Pseudomonas testosteroni by steroidal A ring fused pyrazoles.

Authors:  M A Levy; D A Holt; M Brandt; B W Metcalf
Journal:  Biochemistry       Date:  1987-04-21       Impact factor: 3.162

4.  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.

Authors:  J W Funder; P T Pearce; R Smith; A I Smith
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

5.  Evidence that enzyme-generated aromatic Michael acceptors covalently modify the nucleotide-binding site of 3 alpha-hydroxysteroid dehydrogenase.

Authors:  J W Ricigliano; T M Penning
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

6.  Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs.

Authors:  T M Penning; I Mukharji; S Barrows; P Talalay
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Cloning and sequencing of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase.

Authors:  J E Pawlowski; M Huizinga; T M Penning
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

8.  Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins.

Authors:  T M Penning; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Purification and characterization of NADP+-dependent 3 alpha-hydroxysteroid dehydrogenase from mouse liver cytosol.

Authors:  A Hara; Y Inoue; M Nakagawa; F Naganeo; H Sawada
Journal:  J Biochem       Date:  1988-06       Impact factor: 3.387

10.  Synthesis and evaluation of non-steroidal mechanism-based inactivators of 3 alpha-hydroxysteroid dehydrogenase.

Authors:  J W Ricigliano; T M Penning
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

View more
  18 in total

Review 1.  Human hydroxysteroid dehydrogenases and pre-receptor regulation: insights into inhibitor design and evaluation.

Authors:  Trevor M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2011-01-25       Impact factor: 4.292

Review 2.  Aldo-keto reductases and formation of polycyclic aromatic hydrocarbon o-quinones.

Authors:  Trevor M Penning
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

3.  Modulation of voltage-dependent Shaker family potassium channels by an aldo-keto reductase.

Authors:  Jun Weng; Yu Cao; Noah Moss; Ming Zhou
Journal:  J Biol Chem       Date:  2006-03-28       Impact factor: 5.157

Review 4.  Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor.

Authors:  Trevor M Penning; David R Bauman; Yi Jin; Tea Lanisik Rizner
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

Review 5.  Comparative anatomy of the aldo-keto reductase superfamily.

Authors:  J M Jez; M J Bennett; B P Schlegel; M Lewis; T M Penning
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  Mechanistic studies of morphine dehydrogenase and stabilization against covalent inactivation.

Authors:  E H Walker; C E French; D A Rathbone; N C Bruce
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

7.  Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins.

Authors:  H Ma; T M Penning
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

8.  Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens.

Authors:  Yi Jin; Trevor M Penning
Journal:  Biochemistry       Date:  2006-10-31       Impact factor: 3.162

9.  Identification and functional characterization of sorbitol-6-phosphate dehydrogenase protein from rice and structural elucidation by in silico approach.

Authors:  Rajbala Yadav; Ramasare Prasad
Journal:  Planta       Date:  2014-05-11       Impact factor: 4.116

10.  An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies.

Authors:  Michael C Byrns; Stephan Steckelbroeck; Trevor M Penning
Journal:  Biochem Pharmacol       Date:  2007-09-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.